UTILISATION D'ANTAGONISTES IL-1 POUR TRAITER LA GOUTTE OU LA PSEUDO-GOUTTE

• 收藏
• 分享

专利权人:

INC.;REGENERON PHARMACEUTICALS

发明人:

VICARY, CATHERINE,MELLIS, SCOTT

申请号：

CA2666629

公开号：

CA2666629C

申请日:

2007.10.19

申请国别(地区):

CA

年份:

2016

代理人:

摘要：

Methods of treating, inhibiting, or ameliorating gout, including chronic acute (refractory) gout or pseudogout in a human subject in need thereof, comprising administering to a subject in need a therapeutic amount of an interleukin 1 (IL-1 ) antagonist, wherein gout or pseudogout are inhibited or ameliorated. Preferably, the IL-1 antagonist is the protein of SEQ ID NO:10 (rilonacept).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/